ResMed develops medical devices, mobile apps and cloud-based software that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases.


ResMed and Verily launch Primasun

The clinical sleep care solution aims to reduce untreated sleep disorders' impact on chronic disease and people's lives
ResMed acquires Propeller Health

ResMed to acquire Propeller Health for $225M

The deal will establish ResMed as a leader in COPD patient management, across all stages of the disease; Propeller Health to continue operating as a standalone business.
ResMed AirMini

ResMed’s AirMini updated with remote patient monitoring capability

The feature enables clinicians to see patients' nightly data, verify adherence, and spot issues, enabling them to engage patients to reach better outcomes.

ResMed’s portable, connected CPAP device clears the FDA

The tiny, yet fully-featured AirMini, will be launched later this year to serve as a secondary CPAP, to be used while travelling.

ResMed to acquire Brightree for $800 million

Brightree has developed a cloud-based software that helps customers improve clinical and business performance in the post-acute care industries.
S+ by ResMed

S+ by ResMed announced as the “world’s first non-contact sleep system”

Using patented bio-motion sensors to measure an individual's sleep stages and environment, the device delivers feedback to help improve one's sleep.